Showing results (2281-2290 of 2,365) with videos related to

Sort By:
Pageof 237
The Journal of Infectious Diseases|September 2, 2011
Changes in serogroup and genotype prevalence among carried meningococci in the United Kingdom during vaccine implementationAna Belén Ibarz-Pavón, Jenny Maclennan, Nicholas J Andrews, et al.
Chest|February 13, 2021
Pulmonary Hypertension in Patients With COPD: Results From the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)Carmine Dario Vizza, Marius M Hoeper, Doerte Huscher, et al.
Bioorganic & Medicinal Chemistry Letters|May 8, 2007
Design, synthesis, and SAR of macrocyclic tertiary carbinamine BACE-1 inhibitorsStacey R Lindsley, Keith P Moore, Hemaka A Rajapakse, et al.
Elife|December 19, 2018
Aquaporin-4-dependent glymphatic solute transport in the rodent brainHumberto Mestre, Lauren M Hablitz, Anna Lr Xavier, et al.
The New England Journal of Medicine|April 1, 2025
Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for DeathMarc Humbert, Vallerie V McLaughlin, David B Badesch, et al.
Blood|April 30, 2011
Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacityRoberto F Machado, Robyn J Barst, Nancy A Yovetich, et al.
Nature Microbiology|May 25, 2023
Particular genomic and virulence traits associated with preterm infant-derived toxigenic Clostridium perfringens strainsRaymond Kiu, Alexander G Shaw, Kathleen Sim, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 7, 2025
Identifying dementia risk profiles for targeted interventions: A latent class analysis of at-risk middle-aged AustraliansMuhammad Rehan Sarwar, Amanda J Cross, Kali Godbee, et al.
Journal of Medicinal Chemistry|September 25, 2008
Discovery and X-ray crystallographic analysis of a spiropiperidine iminohydantoin inhibitor of beta-secretaseJames C Barrow, Shaun R Stauffer, Kenneth E Rittle, et al.
The Lancet. Respiratory Medicine|March 27, 2021
Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trialMarius M Hoeper, Hikmet Al-Hiti, Raymond L Benza, et al.
Pageof 237